Functional advantage of NPC-related V-val subtype of Epstein-Barr virus nuclear antigen 1 compared with prototype in epithelial cell line

Oncology Reports

Volumn 17, Issue 1, 2007, Pages 141-146

  Mai, Shi Juan ^a   Ooka, Tadamasa ^b   Li, Da Jiang ^a   Zeng, Mu Sheng ^a   Jiang, Ri Cheng ^a   Yu, Xing Juan ^a   Zhang, Ru Hua ^a   Chen, Shi Ping ^a   Zeng, Yi Xin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

EBNA1; Epstein Barr virus; Nasopharyngeal carcinoma; Variant

Indexed keywords

EBV ENCODED NUCLEAR ANTIGEN 1; EBV-ENCODED NUCLEAR ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN; GREEN FLUORESCENT PROTEIN; ISOPROTEIN;

ARTICLE; BIOSYNTHESIS; CELL GROWTH; CELL LINE; COMPARATIVE STUDY; EPITHELIUM CELL; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENETICS; HUMAN; METABOLISM; NASOPHARYNX TUMOR; PHYSIOLOGY; PLASMID; PROTEIN TERTIARY STRUCTURE; VIROLOGY;

CELL GROWTH PROCESSES; CELL LINE; EPITHELIAL CELLS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GREEN FLUORESCENT PROTEINS; HUMANS; NASOPHARYNGEAL NEOPLASMS; PLASMIDS; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; TRANSFECTION; VARIATION (GENETICS);

EID: 39049196254     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.1.141     Document Type: Article

References (26)

1. Griffin BE: Epstein-Barr virus EBV and human disease: facts, opinions and problems. Mutation Res 462: 395-405, 2000.
2. Feng BJ, Huang W, Shugart YY, Lee MK, Zhang F, Xia JC, Wang HY, Huang TB, Jian SW, Huang P, Feng QS, Huang LX, Yu XJ, Li D, Chen LZ, Jia WH, Fang Y, Huang HM, Zhu JL, Liu XM, Zhao Y, Liu WQ, Deng MQ, Hu WH, Wu SX, Mo HY, Hong MF, King MC, Chen Z and Zeng YX: Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet 31: 395-399, 2002. (Pubitemid 35154449)
3. Zeng MS, Li DJ, Liu QL, Song LB, Li MZ, Zhang RH, Yu XJ, Wang HM, Ernberg I and Zeng YX: Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. J Virol 79: 15323-15330, 2005. (Pubitemid 43032314)
4. Aiyar A, Tyree C and Sugden B: The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element. EMBO J 17: 6394-6403, 1998. (Pubitemid 28497811)
5. Sears J, Ujihara M, Wong S, Ott C, Middeldorp J and Aiyar A: The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes. J Virol 78: 11487-11505, 2004. (Pubitemid 39390736)
6. Wu H, Kapoor P and Frappier L: Separation of the DNA replication, segregation and transcriptional activation functions of Epstein-Barr nuclear antigen 1. J Virol 76: 2480-2490, 2002. (Pubitemid 34150716)
7. Cruickshank J, Shire K, Davidson AR, Edwards AM and Frappier L: Two domains of the epstein-barr virus origin DNA-binding protein, EBNA1, orchestrate sequence-specific DNA binding. J Biol Chem 275: 22273-22277, 2000. (Pubitemid 30621810)
8. Yin Y, Manoury B and Fahraeus R: Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science 301: 1371-1374, 2003. (Pubitemid 37075811)
9. Bhatia K, Raj A, Guitierrez MI, Judde JG, Spangler G, Venkatesh H and Magrath IT: Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene 13: 177-181, 1996. (Pubitemid 26248558)
10. Snudden DK, Smith PR, Lai D, Ng MH and Griffin BE: Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours. Oncogene 10: 1545-1552, 1995.
11. Gutierrez MI, Raj A, Spangler G, Sharma A, Hussain A, Judde JG, Tsao SW, Yuen PW, Joab I, Magrath IT and Bhatia K: Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells. J Gen Virol 78: 1663-1670, 2000.
12. Mai SJ, Zhang XS, Li DJ, Shen GP, Jiang JH, Zhang RH, Yu XJ, Chen SP and Zeng YX: The character of EBNA1 gene variation in Cantonese and its association with nasopharyngeal carcinoma. Chin Sci Bull 49: 2640-2643, 2004.
13. Zhang XS, Wang HH, Hu LF, Li A, Zhang RH, Mai HQ, Xia JC, Chen LZ and Zeng YX: V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma. Cancer Lett 211: 11-18, 2004. (Pubitemid 38759764)
14. Wang WY, Chien YC, Jan JS, Chueh CM and Lin JC: Consistent sequence variation of Epstein-Barr virus nuclear antigen 1 in primary tumor and peripheral blood cells of patients with nasopharyngeal carcinoma. Clin Cancer Res 8: 2586-2590, 2002.
15. Mei YP, Zhu XF, Zhou JM, Huang H, Deng R and Zeng YX: siRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telomerase activity and expression. Cancer Lett 18: 1-10, 2005.
16. Chen MR, Zong J and Hayward SD: Delineation of a 16 amino acid sequence that forms a core DNA recognition motif in the Epstein-Barr virus EBNA-1 protein. Virology 205: 486-495, 1994. (Pubitemid 24371690)
17. Sheu LF, Chen A, Meng CL, Ho KC, Lee WH, Leu FJ and Chao CF: Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo. J Pathol 180: 243-248, 1996. (Pubitemid 26393670)
18. Wilson JB, Bell JL and Levine AJ: Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J 15: 3117-3126, 1996. (Pubitemid 26187759)
19. Kang MS, Lu H, Yasui T, Sharpe A, Warren H, Cahir-McFarland E, Bronson R, Hung SC and Kieff E: Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice. Proc Natl Acad Sci USA 102: 820-825, 2005. (Pubitemid 40282749)
20. Kang MS, Hung SC and Kieff E: Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth. Proc Natl Acad Sci USA 98: 15233-15238, 2001. (Pubitemid 34013997)
21. Sandvej K, Zhou XG and Hamilton-Dutoit S: EBNA-1 sequence variation in Danish and Chinese EBV-associated tumours: evidence for geographical polymorphism but not for tumour-specific subtype restriction. J Pathol 191: 127-131, 2000. (Pubitemid 30394888)
22. Gahn TA and Sugden B: An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J Virol 69: 2633-2636, 1995.
23. Srinivas SK and Sixbey JW: Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2. J Virol 69: 8155-8158, 1995.
24. Kube D, Vockerodt M, Weber O, Hell K, Wolf J, Haier B, Grasser FA, Muller-Lantzsch N, Kieff E, Diehl V and Tesch H: Expression of Epstein-Barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428. J Virol 73: 1630-1636, 1999. (Pubitemid 29036820)
25. Kuhn-Hallek I, Sage DR, Stein L, Groelle H and Fingeroth JD: Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells. Blood 85: 1289-1299, 1995.
26. Tsimbouri P, Drotar ME, Coy JL and Wilson JB: bcl-xL and RAG genes are induced and the response to IL-2 enhanced in EmuEBNA-1 transgenic mouse lymphocytes. Oncogene 21: 5182-5187, 2002.